SUPRIYA

Supriya Lifescience Ltd., headquartered in Mumbai, India, was initially established as a partnership in 1987 and later incorporated as a public limited company in 2008. The company operates in the pharmaceutical industry, specializing in the manufacturing and export of Active Pharmaceutical Ingredients (APIs). Its portfolio includes 38 APIs focused on therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic, and anti-allergic. Supriya Lifescience follows a backward-integrated business model supported by a specialized manufacturing facility and dedicated research and development capabilities. The company serves markets across India and exports to over 120 countries globally. It is recognized as a niche player within the global regulated life science sector.